{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:56:07Z","timestamp":1793465767593,"version":"4.5.0"},"reference-count":139,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.yexcr.2004.11.012","type":"journal-article","created":{"date-parts":[[2004,12,19]],"date-time":"2004-12-19T06:20:11Z","timestamp":1103437211000},"page":"417-431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":196,"title":["Cell responses to FGFR3 signalling: growth, differentiation and apoptosis"],"prefix":"10.1016","volume":"304","author":[{"given":"Corine G.M.","family":"L'H\u00f4te","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2004.11.012_bib1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0168-9525(97)01131-1","article-title":"FGFR activation in skeletal disorders: too much of a good thing","volume":"13","author":"Webster","year":"1997","journal-title":"Trends Genet."},{"key":"10.1016\/j.yexcr.2004.11.012_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1098-1004(1999)14:2<115::AID-HUMU3>3.0.CO;2-2","article-title":"Clinical spectrum of fibroblast growth factor receptor mutations","volume":"14","author":"Passos-Bueno","year":"1999","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.yexcr.2004.11.012_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0378-1119(01)00518-2","article-title":"Identification of a new fibroblast growth factor receptor, FGFR5","volume":"271","author":"Sleeman","year":"2001","journal-title":"Gene"},{"key":"10.1016\/j.yexcr.2004.11.012_bib4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0167-4781(00)00282-7","article-title":"A novel fibroblast growth factor receptor-5 preferentially expressed in the pancreas(1)","volume":"1518","author":"Kim","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexcr.2004.11.012_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s004390050493","article-title":"Human fibroblast growth factor receptor 3 gene (FGFR3): genomic sequence and primer set information for gene analysis","volume":"100","author":"Wuchner","year":"1997","journal-title":"Hum. Genet."},{"key":"10.1016\/j.yexcr.2004.11.012_bib6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S1097-2765(00)00073-3","article-title":"Crystal structure of a ternary FGF\u2013FGFR\u2013heparin complex reveals a dual role for heparin in FGFR binding and dimerization","volume":"6","author":"Schlessinger","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.yexcr.2004.11.012_bib7","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/35039551","article-title":"Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin","volume":"407","author":"Pellegrini","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2004.11.012_bib8","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1074\/jbc.M108540200","article-title":"Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes","volume":"277","author":"Ostrovsky","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2004.11.012_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1042\/bj20021760","article-title":"Heparan sulphate glycosaminoglycans derived from endothelial cells and smooth muscle cells differentially modulate fibroblast growth factor-2 biological activity through fibroblast growth factor receptor-1","volume":"373","author":"Berry","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.yexcr.2004.11.012_bib10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1083\/jcb.200112145","article-title":"Fibroblast growth factor-specific modulation of cellular response by syndecan-4","volume":"157","author":"Horowitz","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1083\/jcb.153.4.811","article-title":"Fibroblast growth factor signaling and basement membrane assembly are connected during epithelial morphogenesis of the embryoid body","volume":"153","author":"Li","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nrc1276","article-title":"Cell adhesion and signalling by cadherins and Ig-CAMs in cancer","volume":"4","author":"Cavallaro","year":"2004","journal-title":"Nat. Rev., Cancer"},{"key":"10.1016\/j.yexcr.2004.11.012_bib13","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/35083041","article-title":"N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling","volume":"3","author":"Cavallaro","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0969-2126(03)00096-0","article-title":"Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP","volume":"11","author":"Kiselyov","year":"2003","journal-title":"Structure (Camb.)"},{"key":"10.1016\/j.yexcr.2004.11.012_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1535-6108(02)00150-2","article-title":"A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor","volume":"2","author":"Suyama","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexcr.2004.11.012_bib16","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1523\/JNEUROSCI.21-15-05587.2001","article-title":"Interactions between fibroblast growth factors and Notch regulate neuronal differentiation","volume":"21","author":"Faux","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.yexcr.2004.11.012_bib17","doi-asserted-by":"crossref","first-page":"16405","DOI":"10.1074\/jbc.M300464200","article-title":"Notch activation suppresses fibroblast growth factor-dependent cellular transformation","volume":"278","author":"Small","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2004.11.012_bib18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0014-5793(93)80882-U","article-title":"A novel form of FGF receptor-3 using an alternative exon in the immunoglobulin domain III","volume":"330","author":"Avivi","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.yexcr.2004.11.012_bib19","doi-asserted-by":"crossref","first-page":"11620","DOI":"10.1016\/S0021-9258(19)78170-8","article-title":"Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF\/FGF-1","volume":"269","author":"Chellaiah","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2004.11.012_bib20","first-page":"5206","article-title":"Identification of a novel variant form of fibroblast growth factor receptor 3 (FGFR3 IIIb) in human colonic epithelium","volume":"54","author":"Murgue","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2004.11.012_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/08977199509036882","article-title":"Identification of fibroblast growth factor 9 (FGF9) as a high affinity, heparin dependent ligand for FGF receptors 3 and 2 but not for FGF receptors 1 and 4","volume":"12","author":"Hecht","year":"1995","journal-title":"Growth Factors"},{"key":"10.1016\/j.yexcr.2004.11.012_bib22","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1074\/jbc.271.3.1726","article-title":"Expression and biological activity of mouse fibroblast growth factor-9","volume":"271","author":"Santos-Ocampo","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2004.11.012_bib23","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.1074\/jbc.272.10.6621","article-title":"Signal transduction pathway of human fibroblast growth factor receptor 3. Identification of a novel 66-kDa phosphoprotein","volume":"272","author":"Kanai","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2004.11.012_bib24","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1101\/gad.965602","article-title":"Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18","volume":"16","author":"Liu","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.yexcr.2004.11.012_bib25","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1101\/gad.965702","article-title":"FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis","volume":"16","author":"Ohbayashi","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.yexcr.2004.11.012_bib26","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1073\/pnas.0307287101","article-title":"Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity","volume":"101","author":"Olsen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2004.11.012_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/dbio.1993.1011","article-title":"Different members of the fibroblast growth factor receptor family are specific to distinct cell types in the developing chicken embryo","volume":"155","author":"Patstone","year":"1993","journal-title":"Dev. Biol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/dvdy.20018","article-title":"Fibroblast growth factor receptor-3 is expressed in undifferentiated intestinal epithelial cells during murine crypt morphogenesis","volume":"230","author":"Vidrich","year":"2004","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.yexcr.2004.11.012_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1242\/dev.00184","article-title":"Fgfr3 expression by astrocytes and their precursors: evidence that astrocytes and oligodendrocytes originate in distinct neuroepithelial domains","volume":"130","author":"Pringle","year":"2003","journal-title":"Development"},{"key":"10.1016\/j.yexcr.2004.11.012_bib30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/dbio.1993.1040","article-title":"Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis","volume":"155","author":"Peters","year":"1993","journal-title":"Dev. Biol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib31","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1242\/dev.128.9.1617","article-title":"Secreted FGFR3, but not FGFR1, inhibits lens fiber differentiation","volume":"128","author":"Govindarajan","year":"2001","journal-title":"Development"},{"key":"10.1016\/j.yexcr.2004.11.012_bib32","first-page":"1185","article-title":"Developmental expression of splicing variants of fibroblast growth factor receptor 3 (FGFR3) in mouse","volume":"40","author":"Wuechner","year":"1996","journal-title":"Int. J. Dev. Biol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.onc.1201908","article-title":"Exon III splicing switch of fibroblast growth factor (FGF) receptor-2 and -3 can be induced by FGF-1 or FGF-2","volume":"17","author":"Scotet","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2004.11.012_bib34","first-page":"G885","article-title":"Cytokine regulation of fibroblast growth factor receptor 3 IIIb in intestinal epithelial cells","volume":"272","author":"Kanai","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib35","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0092-8674(00)81069-7","article-title":"Fibroblast growth factor receptor 3 is a negative regulator of bone growth","volume":"84","author":"Deng","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2004.11.012_bib36","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.2002.17.5.860","article-title":"Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization","volume":"17","author":"Adar","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.yexcr.2004.11.012_bib37","first-page":"23","article-title":"The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans","volume":"21","author":"Vajo","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.yexcr.2004.11.012_bib38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/(SICI)1096-8628(19980707)78:3<274::AID-AJMG14>3.0.CO;2-C","article-title":"Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia","volume":"78","author":"Wilcox","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.yexcr.2004.11.012_bib39","first-page":"362","article-title":"Lys650Met substitution in the tyrosine kinase domain of the fibroblast growth factor receptor gene causes thanatophoric dysplasia Type I. Mutations in brief no. 199","volume":"12","author":"Kitoh","year":"1998","journal-title":"Online, Hum. Mutat."},{"key":"10.1016\/j.yexcr.2004.11.012_bib40","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1086\/302275","article-title":"A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene","volume":"64","author":"Tavormina","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.yexcr.2004.11.012_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1096-8628(19990702)85:1<53::AID-AJMG10>3.0.CO;2-F","article-title":"Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3","volume":"85","author":"Bellus","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.yexcr.2004.11.012_bib42","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1128\/MCB.16.8.4081","article-title":"Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II","volume":"16","author":"Webster","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib43","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/316892","article-title":"Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype","volume":"67","author":"Bellus","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.yexcr.2004.11.012_bib44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/hmg\/5.4.509","article-title":"Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1)","volume":"5","author":"Rousseau","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2004.11.012_bib45","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1073\/pnas.95.8.4567","article-title":"Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain","volume":"95","author":"Robertson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2004.11.012_bib46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/ng0595-11","article-title":"Stop codon FGFR3 mutations in thanatophoric dwarfism type 1","volume":"10","author":"Rousseau","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexcr.2004.11.012_bib47","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1128\/MCB.20.2.516-522.2000","article-title":"The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation","volume":"20","author":"Monsonego-Ornan","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib48","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-5793(02)03255-6","article-title":"FGF receptors ubiquitylation: dependence on tyrosine kinase activity and role in downregulation","volume":"528","author":"Monsonego-Ornan","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.yexcr.2004.11.012_bib49","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1073\/pnas.2237184100","article-title":"Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia","volume":"101","author":"Cho","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2004.11.012_bib50","doi-asserted-by":"crossref","first-page":"17344","DOI":"10.1074\/jbc.M212710200","article-title":"The thanatophoric dysplasia type II mutation hampers complete maturation of fibroblast growth factor receptor 3 (FGFR3), which activates signal transducer and activator of transcription 1 (STAT1) from the endoplasmic reticulum","volume":"278","author":"Lievens","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2004.11.012_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1152\/physiolgenomics.2000.2.1.9","article-title":"A novel mutation in FGFR-3 disrupts a putative N-glycosylation site and results in hypochondroplasia","volume":"2","author":"Winterpacht","year":"2000","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.yexcr.2004.11.012_bib52","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/hmg\/ddh011","article-title":"Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity","volume":"13","author":"Ibrahimi","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2004.11.012_bib53","doi-asserted-by":"crossref","first-page":"R589","DOI":"10.1016\/S0960-9822(01)00359-1","article-title":"Endochondral ossification: a delicate balance between growth and mineralisation","volume":"11","author":"White","year":"2001","journal-title":"Curr. Biol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/hmg\/9.2.249","article-title":"Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice","volume":"9","author":"Segev","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2004.11.012_bib55","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1073\/pnas.96.8.4455","article-title":"A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3","volume":"96","author":"Wang","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2004.11.012_bib56","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1172\/JCI6690","article-title":"Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis","volume":"104","author":"Chen","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2004.11.012_bib57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/hmg\/8.1.35","article-title":"A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors","volume":"8","author":"Li","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2004.11.012_bib58","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/hmg\/9.11.1603","article-title":"A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos","volume":"9","author":"Iwata","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2004.11.012_bib59","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/hmg\/10.12.1255","article-title":"Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice","volume":"10","author":"Iwata","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2004.11.012_bib60","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/hmg\/10.5.457","article-title":"A Ser(365)\u2014Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh\/PTHrP signals and causes severe achondroplasia","volume":"10","author":"Chen","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2004.11.012_bib61","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bone.2003.09.002","article-title":"Overexpression of FGFR3, Stat1, Stat5 and p21(Cip1) correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias","volume":"34","author":"Legeai-Mallet","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.yexcr.2004.11.012_bib62","doi-asserted-by":"crossref","first-page":"13007","DOI":"10.1074\/jbc.273.21.13007","article-title":"Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia","volume":"273","author":"Legeai-Mallet","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2004.11.012_bib63","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1242\/jcs.115.3.553","article-title":"Induction of chondrocyte growth arrest by FGF: transcriptional and cytoskeletal alterations","volume":"115","author":"Rozenblatt-Rosen","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.yexcr.2004.11.012_bib64","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1083\/jcb.200302075","article-title":"A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation","volume":"161","author":"Dailey","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib65","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1359\/jbmr.2000.15.1.155","article-title":"Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells","volume":"15","author":"Henderson","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.yexcr.2004.11.012_bib66","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1242\/dev.128.19.3867","article-title":"Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains","volume":"128","author":"Wang","year":"2001","journal-title":"Development"},{"key":"10.1016\/j.yexcr.2004.11.012_bib67","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/hmg\/ddh034","article-title":"Defective bone mineralization and osteopenia in young adult FGFR3\u2212\/\u2212 mice","volume":"13","author":"Valverde-Franco","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2004.11.012_bib68","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0002-9440(10)64409-4","article-title":"Parathyroid hormone receptor type 1\/Indian hedgehog expression is preserved in the growth plate of human fetuses affected with fibroblast growth factor receptor type 3 activating mutations","volume":"161","author":"Cormier","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bone.2003.08.009","article-title":"Signalling by fibroblast growth factor receptor 3 and parathyroid hormone-related peptide coordinate cartilage and bone development","volume":"34","author":"Amizuka","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.yexcr.2004.11.012_bib70","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/9467","article-title":"VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation","volume":"5","author":"Gerber","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2004.11.012_bib71","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/ng0797-260","article-title":"Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3","volume":"16","author":"Chesi","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexcr.2004.11.012_bib72","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1182\/blood.V90.10.4062","article-title":"A novel chromosomal translocation t(4;14)(p16.3;q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene","volume":"90","author":"Richelda","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2004.11.012_bib73","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/12615","article-title":"Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas","volume":"23","author":"Cappellen","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexcr.2004.11.012_bib74","first-page":"3541","article-title":"Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers","volume":"61","author":"Jang","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2004.11.012_bib75","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/1097-0215(20000801)87:3<455::AID-IJC23>3.0.CO;2-Q","article-title":"No evidence for fibroblast growth factor receptor 3 (FGFR-3) R248C\/S249C mutations in human prostate cancer","volume":"87","author":"Naimi","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2004.11.012_bib76","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1038\/sj.onc.1204651","article-title":"No evidence of somatic FGFR3 mutation in various types of carcinoma","volume":"20","author":"Karoui","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2004.11.012_bib77","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1038\/sj.onc.1204543","article-title":"Frequency of fibroblast growth factor receptor 3 mutations in sporadic tumours","volume":"20","author":"Sibley","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2004.11.012_bib78","first-page":"4546","article-title":"14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myelome","volume":"59","author":"Avet-Loiseau","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2004.11.012_bib79","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1365-2141.2002.03618.x","article-title":"A molecular study of the t(4;14) in multiple myeloma","volume":"118","author":"Sibley","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib80","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood.V99.5.1745","article-title":"Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells","volume":"99","author":"Zhan","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2004.11.012_bib81","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1182\/blood-2002-06-1675","article-title":"In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression","volume":"101","author":"Keats","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2004.11.012_bib82","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1182\/blood-2002-09-2801","article-title":"A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH\/MMSET fusion transcript","volume":"101","author":"Santra","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2004.11.012_bib83","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1182\/blood-2003-04-1204","article-title":"Mutation, SNP, and isoform analysis of fibroblast growth factor receptor 3 (FGFR3) in 150 newly diagnosed multiple myeloma patients","volume":"102","author":"Onwuazor","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2004.11.012_bib84","first-page":"1036","article-title":"Novel mutation and RNA splice variant of fibroblast growth factor receptor 3 in multiple myeloma patients at diagnosis","volume":"87","author":"Soverini","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.yexcr.2004.11.012_bib85","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1182\/blood.V97.3.729","article-title":"Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma","volume":"97","author":"Chesi","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2004.11.012_bib86","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1182\/blood.V97.8.2413","article-title":"The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells","volume":"97","author":"Li","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2004.11.012_bib87","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1034\/j.1600-065X.2003.00052.x","article-title":"Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma","volume":"194","author":"Bergsagel","year":"2003","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.yexcr.2004.11.012_bib88","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/sj.leu.2403347","article-title":"Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074","volume":"18","author":"Grand","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.yexcr.2004.11.012_bib89","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.ejhg.5200883","article-title":"Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders","volume":"10","author":"Van Rhijn","year":"2002","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.yexcr.2004.11.012_bib90","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00001622-200205000-00003","article-title":"Bladder cancer","volume":"14","author":"Patton","year":"2002","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib91","series-title":"TNM Classification of Malignant Tumors, Bladder","author":"UICC","year":"1978"},{"key":"10.1016\/j.yexcr.2004.11.012_bib92","unstructured":"WHO, Histological typing of urinary bladder tumours, Int. Histol. Classif. Tumours, 1973."},{"key":"10.1016\/j.yexcr.2004.11.012_bib93","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1002\/1097-0142(20011115)92:10<2555::AID-CNCR1607>3.0.CO;2-M","article-title":"The incidence of thanatophoric dysplasia mutations in FGFR3 gene is higher in low-grade or superficial bladder carcinomas","volume":"92","author":"Kimura","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.yexcr.2004.11.012_bib94","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0002-9440(10)64665-2","article-title":"Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors","volume":"158","author":"Billerey","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib95","first-page":"8108","article-title":"FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder","volume":"63","author":"Bakkar","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2004.11.012_bib96","first-page":"1265","article-title":"The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate","volume":"61","author":"van Rhijn","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2004.11.012_bib97","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1054\/bjoc.2000.1557","article-title":"Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67","volume":"84","author":"Tut","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexcr.2004.11.012_bib98","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1442-2042.2000.00212.x","article-title":"Immunohistochemical demonstration of cyclin D1 in bladder cancers as an inverse indicator of invasiveness but not an independent prognostic factor","volume":"7","author":"Takagi","year":"2000","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib99","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<780::AID-CNCR15>3.0.CO;2-W","article-title":"Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features","volume":"79","author":"Lee","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.yexcr.2004.11.012_bib100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1096-9896(199905)188:1<44::AID-PATH320>3.0.CO;2-Q","article-title":"Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer","volume":"188","author":"Wagner","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib101","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0022-5347(01)62829-5","article-title":"Cyclin D1 protein overexpression is related to tumor differentiation, but not to tumor progression or proliferative activity, in transitional cell carcinoma of the bladder","volume":"160","author":"Suwa","year":"1998","journal-title":"J. Urol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib102","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/ijc.10055","article-title":"Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome","volume":"97","author":"Sgambato","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2004.11.012_bib103","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1200\/JCO.2003.05.073","article-title":"Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome","volume":"21","author":"van Rhijn","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib104","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1182\/blood-2003-10-3650","article-title":"Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t(4;14) myeloma","volume":"103","author":"Trudel","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2004.11.012_bib105","doi-asserted-by":"crossref","first-page":"11031","DOI":"10.1074\/jbc.M003535200","article-title":"A novel alternatively spliced fibroblast growth factor receptor 3 isoform lacking the acid box domain is expressed during chondrogenic differentiation of ATDC5 cells","volume":"276","author":"Shimizu","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2004.11.012_bib106","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/bbrc.2001.6190","article-title":"FGFR3 isoforms have distinct functions in the regulation of growth and cell morphology","volume":"290","author":"Shimizu","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2004.11.012_bib107","doi-asserted-by":"crossref","first-page":"30643","DOI":"10.1074\/jbc.270.51.30643","article-title":"Fibroblast growth factor receptors (FGFRs) localize in different cellular compartments. A splice variant of FGFR-3 localizes to the nucleus","volume":"270","author":"Johnston","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2004.11.012_bib108","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/path.846","article-title":"Altered intracellular localization of fibroblast growth factor receptor 3 in human breast cancer","volume":"194","author":"Zammit","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib109","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/mcbr.2001.0306","article-title":"Fibroblast growth factor receptor 3 lacking the Ig IIIb and transmembrane domains secreted from human squamous cell carcinoma DJM-1 binds to FGFs","volume":"4","author":"Terada","year":"2001","journal-title":"Mol. Cell. Biol. Res. Commun."},{"key":"10.1016\/j.yexcr.2004.11.012_bib110","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1006\/bbrc.2002.6668","article-title":"Identification and characterization of soluble isoform of fibroblast growth factor receptor 3 in human SaOS-2 osteosarcoma cells","volume":"292","author":"Jang","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2004.11.012_bib111","first-page":"4049","article-title":"Novel transcripts of fibroblast growth factor receptor 3 reveal aberrant splicing and activation of cryptic splice sequences in colorectal cancer","volume":"60","author":"Jang","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2004.11.012_bib112","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/sj.bjc.6601249","article-title":"FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells","volume":"89","author":"Sturla","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexcr.2004.11.012_bib113","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/MCB.16.3.977","article-title":"Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction","volume":"16","author":"Mohammadi","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib114","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1091\/mbc.12.4.931","article-title":"Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation","volume":"12","author":"Hart","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.yexcr.2004.11.012_bib115","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0092-8674(00)80252-4","article-title":"A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras\/MAPK signaling pathway","volume":"89","author":"Kouhara","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2004.11.012_bib116","first-page":"5068","article-title":"A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1","volume":"11","author":"Mohammadi","year":"1991","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib117","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1038\/sj.onc.1203650","article-title":"Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4","volume":"19","author":"Hart","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2004.11.012_bib118","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1074\/jbc.M002959200","article-title":"Fibroblast growth factor receptor 3 induces gene expression primarily through Ras-independent signal transduction pathways","volume":"276","author":"Choi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2004.11.012_bib119","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng0696-233","article-title":"Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia","volume":"13","author":"Naski","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexcr.2004.11.012_bib120","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1128\/MCB.17.10.5739","article-title":"Enhanced signaling and morphological transformation by a membrane-localized derivative of the fibroblast growth factor receptor 3 kinase domain","volume":"17","author":"Webster","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib121","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1101\/gad.13.11.1361","article-title":"FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway","volume":"13","author":"Sahni","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.yexcr.2004.11.012_bib122","doi-asserted-by":"crossref","first-page":"29347","DOI":"10.1074\/jbc.M101859200","article-title":"Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2","volume":"276","author":"Aikawa","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2004.11.012_bib123","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1073\/pnas.96.4.1433","article-title":"Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes","volume":"96","author":"Beier","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2004.11.012_bib124","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1091\/mbc.12.12.3852","article-title":"TGFbeta and PTHrP control chondrocyte proliferation by activating cyclin D1 expression","volume":"12","author":"Beier","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.yexcr.2004.11.012_bib125","first-page":"1750","article-title":"Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events","volume":"57","author":"Wang","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2004.11.012_bib126","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1523\/JNEUROSCI.15-09-06200.1995","article-title":"NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1","volume":"15","author":"Yan","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.yexcr.2004.11.012_bib127","first-page":"699","article-title":"Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kip1, inhibits growth, and enhances apoptosis","volume":"7","author":"Han","year":"1996","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.yexcr.2004.11.012_bib128","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/mp.52.2.78","article-title":"Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas","volume":"52","author":"de Jong","year":"1999","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.yexcr.2004.11.012_bib129","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1074\/jbc.M310384200","article-title":"Activation of the ERK1\/2 and p38 mitogen-activated protein kinase pathways mediates fibroblast growth factor-induced growth arrest of chondrocytes","volume":"279","author":"Raucci","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2004.11.012_bib130","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1359\/jbmr.2003.18.11.2043","article-title":"Insulin-like growth factor-1 rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase and MAPK","volume":"18","author":"Koike","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.yexcr.2004.11.012_bib131","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nm971","article-title":"Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway","volume":"10","author":"Yasoda","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2004.11.012_bib132","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1101\/gad.1179104","article-title":"Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype","volume":"18","author":"Murakami","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.yexcr.2004.11.012_bib133","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1042\/bj20030874","article-title":"p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation","volume":"378","author":"Stanton","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.yexcr.2004.11.012_bib134","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1038\/sj.onc.1204465","article-title":"Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations","volume":"20","author":"Ronchetti","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2004.11.012_bib135","doi-asserted-by":"crossref","first-page":"15962","DOI":"10.1074\/jbc.M102777200","article-title":"Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation","volume":"277","author":"Kong","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2004.11.012_bib136","doi-asserted-by":"crossref","first-page":"28450","DOI":"10.1074\/jbc.M403335200","article-title":"The cytoplasmic tyrosine kinase Pyk2 as a novel effector of fibroblast growth factor receptor 3 activation","volume":"279","author":"Meyer","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2004.11.012_bib137","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/emboj\/18.5.1367","article-title":"Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells","volume":"18","author":"Matsumura","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.yexcr.2004.11.012_bib138","doi-asserted-by":"crossref","first-page":"21237","DOI":"10.1074\/jbc.M110955200","article-title":"Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism","volume":"277","author":"Deo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2004.11.012_bib139","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/sj.onc.1204110","article-title":"Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma","volume":"20","author":"Sibley","year":"2001","journal-title":"Oncogene"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448270400686X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448270400686X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T03:40:49Z","timestamp":1757994049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448270400686X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":139,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S001448270400686X"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2004.11.012","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell responses to FGFR3 signalling: growth, differentiation and apoptosis","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2004.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}